Source: http://www.esmo.org/Conferences/Past-Conferences/ESMO-2014-Congress/Press-Media/Adding-Cediranib-to-Chemotherapy-Improves-Progression-Free-Survival-for-Metastatic-or-Recurrent-Cervical-Cancer-Phase-II-Trial-Shows